25 results on '"Beullens, Monique"'
Search Results
2. Functions and therapeutic potential of protein phosphatase 1: Insights from mouse genetics.
- Author
-
Ferreira, Mónica, Beullens, Monique, Bollen, Mathieu, and Van Eynde, Aleyde
- Subjects
- *
PHOSPHOPROTEIN phosphatases , *MICE genetics , *DEPHOSPHORYLATION , *PHOSPHORYLATION , *PROTEIN structure - Abstract
Abstract Protein phosphatase 1 (PP1) catalyzes more than half of all phosphoserine/threonine dephosphorylation reactions in mammalian cells. In vivo PP1 does not exist as a free catalytic subunit but is always associated with at least one regulatory PP1-interacting protein (PIP) to generate a large set of distinct holoenzymes. Each PP1 complex controls the dephosphorylation of only a small subset of PP1 substrates. We screened the literature for genetically engineered mouse models and identified models for all PP1 isoforms and 104 PIPs. PP1 itself and at least 49 PIPs were connected to human disease-associated phenotypes. Additionally, phenotypes related to 17 PIPs were clearly linked to altered PP1 function, while such information was lacking for 32 other PIPs. We propose structural reverse genetics, which combines structural characterization of proteins with mouse genetics, to identify new PP1-related therapeutic targets. The available mouse models confirm the pleiotropic action of PP1 in health and diseases. Highlights • Four protein phosphatases 1 (PP1) isoforms and >200 PP1-interacting proteins (PIPs) • Genetically engineered mice of 49 PIPs display human disease-associated phenotypes. • The use of structural reverse genetics to identify the PP1-dependent phenotypes • Various interaction sites in PP1:PIP complexes suit for therapeutic targeting. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
3. Glucose-dependent regulation of AMP-activated protein kinase in MIN6 beta cells is not affected by the protein kinase A pathway
- Author
-
Garcia-Haro, Luisa, Garcia-Gimeno, Maria Adelaida, Neumann, Dietbert, Beullens, Monique, Bollen, Mathieu, and Sanz, Pascual
- Published
- 2012
- Full Text
- View/download PDF
4. Determinants of the nucleolar targeting of protein phosphatase-1
- Author
-
Lesage, Bart, Beullens, Monique, Ceulemans, Hugo, Himpens, Bernard, and Bollen, Mathieu
- Published
- 2005
- Full Text
- View/download PDF
5. Maternal Embryonic Leucine Zipper Kinase (MELK) Reduces Replication Stress in Glioblastoma Cells.
- Author
-
Kig, Cenk, Beullens, Monique, Beke, Lijs, Van Eynde, Aleyde, Linders, Johannes T., Brehmer, Dirk, and Bollen, Mathieu
- Subjects
- *
LEUCINE zippers , *CELL cycle , *CELL death , *RETINOBLASTOMA , *BRAIN tumors , *PROTEIN kinases - Abstract
Maternal embryonic leucine zipper kinase (MELK) belongs to the subfamily of AMP-activated Ser/Thr protein kinases. The expression of MELK is very high in glioblastoma-type brain tumors, but it is not clear how this contributes to tumor growth. Here we show that the siRNA-mediated loss of MELK in U87 MG glioblastoma cells causes a G1/S phase cell cycle arrest accompanied by cell death or a senescence-like phenotype that can be rescued by the expression of siRNA-resistant MELK. This cell cycle arrest is mediated by an increased expression of p21WAF1/CIP1, an inhibitor of cyclin-dependent kinases, and is associated with the hypophosphorylation of the retinoblastoma protein and the down-regulation of E2F target genes. The increased expression of p21 can be explained by the consecutive activation of ATM(ataxia telangiectasia mutated), Chk2, and p53. Intriguingly, the activation of p53 in MELK-deficient cells is not due to an increased stability of p53 but stems from the loss of MDMX (mouse double minute-X), an inhibitor of p53 transactivation. The activation of the ATM-Chk2 pathway in MELK-deficient cells is associated with the accumulation of DNA double-strand breaks during replication, as demonstrated by the appearance of γH2AX foci. Replication stress in these cells is also illustrated by an increased number of stalled replication forks and a reduced fork progression speed. Our data indicate that glioblastoma cells have elevated MELK protein levels to better cope with replication stress during unperturbed S phase. Hence, MELK inhibitors hold great potential for the treatment of glioblastomas as such or in combination with DNA-damaging therapies. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
6. Nature of the nuclear inclusions formed by PQBP1, a protein linked to neurodegenerative polyglutamine diseases
- Author
-
Nicolaescu, Emilia, Beullens, Monique, Lesage, Bart, Keppens, Stefaan, Himpens, Bernard, and Bollen, Mathieu
- Subjects
- *
NEURODEGENERATION , *CARRIER proteins , *FRIEDREICH'S ataxia , *MESSENGER RNA , *NUCLEIC acids , *GLUTAMINE - Abstract
Abstract: PQBP1, for polyglutamine tract-binding protein-1, has been linked to progressive neurodegenerative diseases, such as spinocerebellar ataxia, that are caused by the expansion of a polyglutamine repeat in a key regulatory protein. The overexpression of PQBP1 results in the formation of nuclear inclusions, reminiscent of the protein aggregates that are detected in polyglutamine diseases. We show here that the occurrence of PQBP1-induced nuclear inclusions is dramatically increased by the co-expression of the pre-mRNA splicing factor SIPP1, a protein ligand of PQBP1. These nuclear inclusions did not co-localise with nuclear structures such as nucleoli, coiled bodies, PML bodies, speckles and stress bodies, and were not associated with (in)active chromatin or with nucleic acids. Site-directed mutagenesis showed that the facilitation in the formation of the nuclear inclusions required multiple independent interaction sites between SIPP1 and PQBP1. Moreover, the nuclear inclusions were highly dynamic and their formation did not require energy. Our data suggest that the SIPP1–PQBP1-induced nuclear inclusions are distinct from the protein aggregates that are associated with polyglutamine diseases and represent dynamic nucleoplasmic heteropolymers of SIPP1 and PQBP1. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
7. Substrate Specificity and Activity Regulation of Protein Kinase MELK.
- Author
-
Beullens, Monique, Vancauwenbergh, Sadia, Morrice, Nick, Derua, Rita, Ceulemans, Hugo, Waelkens, Etienne, and Bollen, Mathieu
- Subjects
- *
PROTEIN kinases , *LEUCINE zippers , *STEM cells , *RNA splicing , *MESSENGER RNA , *PHOSPHORYLATION , *TYROSINE , *CARRIER proteins - Abstract
Maternal embryonic leucine zipper kinase (MELK) is a protein Ser/Thr kinase that has been implicated in stem cell renewal, cell cycle progression, and pre-mRNA splicing, but its substrates and regulation are not yet known. We show here that MELK has a rather broad substrate specificity and does not appear to require a specific sequence surrounding its (auto)phosphorylation sites. We have mapped no less than 16 autophosphorylation sites including serines, threonines, and a tyrosine residue and show that the phosphorylation of Thr167 and Ser171 is required for the activation of MELK. The expression of MELK activity also requires reducing agents such as dithiothreitol or reduced glutathione. Furthermore, we show that MELK is a Ca2+-binding protein and is inhibited by physiological Ca2+ concentrations. The smallest MELK fragment that was still catalytically active comprises the N-terminal catalytic domain and the flanking ubiquitin-associated domain. A C-terminal fragment of MELK functions as an autoinhibitory domain. Our data show that the activity of MELK is regulated in a complex manner and offer new perspectives for the further elucidation of its biological function. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
8. Nucleocytoplasmic Shuttling of the Splicing Factor SIPP1.
- Author
-
Llorian, Miriam, Beullens, Monique, Lesage, Bart, Nicolaescu, Emilia, Beke, Lijs, Landuyt, Willy, Ortiz, José-Miguel, and Bollen, Mathieu
- Subjects
- *
MESSENGER RNA , *GENETIC engineering , *CARRIER proteins , *FRAGILE X syndrome , *HUMAN abnormality genetics , *X chromosome abnormalities , *NEURODEGENERATION , *MEDICAL genetics - Abstract
SIPP1 (splicing factor that interacts with PQBP1 and PP1) is a widely expressed protein of 70 kDa that has been implicated in pre-mRNA splicing. It interacts with protein Ser/Thr phosphatase-1 (PP1) and with the polyglutamine-tract-binding protein 1 (PQBP 1), which contributes to the pathogenesis of X-linked mental retardation and neurodegenerative diseases caused by polyglutamine tract expansions. We show here that SIPP1 is a nucleocytoplasmic shuttling protein. Under basal circumstances SIPP1 was largely nuclear, but it accumulated in the cytoplasm following UV- or X-radiation. Nuclear import was mediated by two nuclear localization signals. In addition, SIPP1 could be piggy-back transported to the nucleus with its ligand PQBP1. In the nucleus SIPP1 and PQBP1 formed inclusion bodies similar to those detected in polyglutamine diseases. SIPP1 did not function as a nuclear targeting subunit of PP1 but re-localized nuclear PP1 to storage sites for splicing factors. The C-terminal residues of SIPP1, which do not conform to a classic nuclear export signal, were required for its nuclear export via the CMR-1 pathway. Finally, SIPP1 activated pre-mRNA splicing in intact cells, and the extent of splicing activation correlated with the nuclear concentration of SIPP1. We conclude that SIPP1 is a positive regulator of pre-mRNA splicing that is regulated by nucleocytoplasmic shuttling. These findings also have potential implications for a better understanding of the pathogenesis of X-linked mental retardation and polyglutamine-linked neurodegenerative disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
9. Inhibition of Spliceosome Assembly by the Cell Cycle-regulated Protein Kinase MELK and Involvement of Splicing Factor NIPP1.
- Author
-
Vulsteke, Veerle, Beullens, Monique, Boudrez, An, Keppens, Stefaan, Van Eynde, Aleyde, Rider, Mark H., Stalmans, Willy, and Bollen, Mathieu
- Subjects
- *
PROTEINS , *CELL cycle , *LEUCINE , *MESSENGER RNA , *CELLS - Abstract
NIPP1 is a ubiquitous nuclear protein that is required for spliceosome assembly. We report here that the phosphothreonine-binding Forkhead-associated domain of NIPP1 interacts with the cell cycle-regulated protein Ser/Thr kinase MELK (maternal embryonic leucine zipper kinase). The NIPP1-MELK interaction was critically dependent on the phosphorylaton of Thr-478 of MELK and was increased in lysates from mitotically arrested cells. Recombinant MELK was a potent inhibitor of an early step of spliceosome assembly in nuclear extracts. This splicing defect was also seen with a kinase-dead mutant but was absent after mutation (T478A) of the NIPP1 binding site of MELK, indicating a mediatory role for NIPP1. Our data suggest that MELK has a role in the cell cycle-regulated control of pre-mRNA splicing. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
10. Degeneracy and Function of the Ubiquitous RVXF Motif That Mediates Binding to Protein Phosphatase-1.
- Author
-
Wakula, Paulina, Beullens, Monique, Ceulemans, Hugo, Stalmans, Willy, and Bollen, Mathieu
- Subjects
- *
LIGAND binding (Biochemistry) , *PHOSPHOPROTEIN phosphatases - Abstract
Investigates the degeneracy and function of the ubiquitous sequence that mediates binding to protein phosphatase-1. Combination of sequence alignments and the and site-directed mutagenesis; Determination of the inhibitory potency of the regulators; Anchorage functions of the motifs.
- Published
- 2003
- Full Text
- View/download PDF
11. <atl>Signaling by protein phosphatases in the nucleus
- Author
-
Bollen, Mathieu and Beullens, Monique
- Subjects
- *
PHOSPHOPROTEIN phosphatases , *CELLULAR signal transduction , *CELL cycle , *CELL nuclei - Abstract
The nucleus contains a large variety of protein phosphatases, which function in key processes such as cell-cycle progression, replication, transcription and RNA processing. Here, we review the pleiotropic action of nuclear protein phosphatases and focus in particular on the underlying signaling strategies. It appears that nuclear protein phosphatases can both mediate and antagonize signaling by protein kinases, sometimes as part of feedback loops. Some protein phosphatases shuttle between the cytoplasm and the nucleus, which enables them to act as signal transducers between both compartments. An emerging theme is the contribution of protein phosphatases to cycles of protein phosphorylation and dephosphorylation that steer the assembly and firing of molecular machines in the nucleus. [ABSTRACT FROM AUTHOR]
- Published
- 2002
- Full Text
- View/download PDF
12. Identification of sds22 as an inhibitory subunit of protein phosphatase-1 in rat liver nuclei
- Author
-
Dinischiotu, Anca, Beullens, Monique, Stalmans, Willy, and Bollen, Mathieu
- Published
- 1997
- Full Text
- View/download PDF
13. Molecular cloning of a human polypeptide related to yeast sds22, a regulator of protein phosphatase-1
- Author
-
Renouf, Sylvie, Beullens, Monique, Wera, Stefaan, Van Eynde, Aleyde, Sikela, James, Stalmans, Willy, and Bollen, Mathieu
- Published
- 1995
- Full Text
- View/download PDF
14. Metals in the active site of native protein phosphatase-1.
- Author
-
Heroes, Ewald, Rip, Jens, Beullens, Monique, Van Meervelt, Luc, De Gendt, Stefan, and Bollen, Mathieu
- Subjects
- *
BINDING sites , *PHOSPHOPROTEIN phosphatases , *EUKARYOTIC cells , *METAL ions , *CATALYSIS , *X-ray fluorescence - Abstract
Protein phosphatase-1 (PP1) is a major protein Ser/Thr phosphatase in eukaryotic cells. Its activity depends on two metal ions in the catalytic site, which were identified as manganese in the bacterially expressed phosphatase. However, the identity of the metal ions in native PP1 is unknown. In this study, total reflection X-ray fluorescence (TXRF) was used to detect iron and zinc in PP1 that was purified from rabbit skeletal muscle. Metal exchange experiments confirmed that the distinct substrate specificity of recombinant and native PP1 is determined by the nature of their associated metals. We also found that the iron level associated with native PP1 is decreased by incubation with inhibitor-2, consistent with a function of inhibitor-2 as a PP1 chaperone. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
15. Nuclear Targeting of Protein Phosphatase-1 by HIV-1 Tat Protein.
- Author
-
Ammosova, Tatyana, Jerebtsova, Marina, Beullens, Monique, Lesage, Bart, Jackson, Angela, Kashanchi, Fatah, Southerland, William, Gordeuk, Victor R., Bollen, Mathieu, and Nekhai, Sergei
- Subjects
- *
PHOSPHOPROTEIN phosphatases , *FELINE immunodeficiency virus , *MEDICAL transcription , *PROTEIN metabolism , *PROTEINS , *PHOSPHORYLATION - Abstract
Transcription of human immunodeficiency virus (HIV)-1 genes is activated by HIV-1 Tat protein, which induces phosphorylation of the C-terminal domain of RNA polymerase-II by CDK9/cyclin T1. We previously showed that Tat-induced HIV-1 transcription is regulated by protein phosphatase-1 (PP1). In the present study we demonstrate that Tat interacts with PP1 and that disruption of this interaction prevents induction of HIV-1 transcription. We show that PP1 interacts with Tat in part through the binding of Val36 and Phe38 of Tat to PP1 and that Tat is involved in the nuclear and subnuclear targeting of PP1. The PP1 binding mutant Tat-V36A/F38A displayed a decreased affinity for PP1 and was a poor activator of HIV-1 transcription. Surprisingly, Tat-Q35R mutant that had a higher affinity for PP1 was also a poor activator of HIV-1 transcription, because strong PP1 binding competed out binding of Tat to CDK9/cyclin T1. Our results suggest that Tat might function as a nuclear regulator of PP1 and that interaction of Tat with PP1 is critical for activation of HIV-1 transcription by Tat. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
16. Nuclear Protein Phosphatase-1 Regulates HIV-1 Transcription.
- Author
-
Ammosova, Tatyana, Jerebtsova, Marina, Beullens, Monique, Voloshin, Yaroslav, Ray, Patricio E., Kumar, Ajit, Bollen, Mathieu, and Nekhai, Sergei
- Subjects
- *
PHOSPHOPROTEIN phosphatases , *RNA polymerases - Abstract
We recently reported that protein phosphatase 1 (PP1) dephosphorylates RNA polymerase II C-terminal repeats and regulates HIV-1 transcription in vitro. Here we provide evidence that PPi is also required for Tatinduced HIV-1 transcription and for viral replication in cultured cells. Inhibition of PP1 by overexpression of nuclear inhibitor of PP1 (NIPP1) inhibited Tat-induced HIV-1 transcription in transient transfection assays. A mutant of NIPP1 that was defective in binding to PP1 did not have this effect. Also the co-expression of PP1γ reversed the inhibitory effect of NIPP1. Adeno-associated virus-mediated delivery of NIPP1 significantly reduced HIV-1 transcription induced by Tat-expressing adenovirus in CD4+ HeLa cells that contained an integrated HIV-1 promoter (HeLa MAGI cells). In addition, infection of HeLa MAGI cells with adeno-associated virus-NIPP1 prior to the infection with HIV-1 significantly reduced the level of HIV-1 replication. Our results indicate that PP1 might be a host cell factor that is required for HIV-1 viral transcription. Therefore, nuclear PP1 may represent a novel target for anti-HIV-1 therapeutics. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
17. The Protein Phosphatase-1 (PP1) Regulator, Nuclear Inhibitor of PP1 (NIPP1), Interacts with the Polycomb Group Protein, Embryonic Ectoderm Development (EED), and Functions as a Transcriptional Repressor.
- Author
-
Qiming Jin, van Eynde, Aleyde, Beullens, Monique, Roy, Nivedita, Thiel, Gerald, Stalmans, Willy, and Bollen, Mathieu
- Subjects
- *
PHOSPHOPROTEIN phosphatases , *GENETIC transcription - Abstract
The nuclear protein NIPP1 (nuclear inhibitor of protein Ser/Thr ohosphatase-1) interacts with the splicing factors SAP155 and CDC5L and is involved in a late step of spliceosome assembly. In addition, NIPP1 is an interactor of protein phosphatase-1 and a COOH-terminal NIPP1 fragment displays an RNase E like endoribonuclease activity. A yeast two-hybrid screening resulted in the identification of the Polycomb group protein EED (embryonic ectoderm development), an established transcriptional repressor, as a novel NIPP1 interactor. NIPP1 only interacted with full-length EED, whereas two EED interaction domains were mapped to the central and COOH-terminal thirds of NIPP1. The NIPP1EED interaction was potentiated by the binding of (d)Grich nucleic acids to the central domain of NIPPI. Nucleic acids also decreased the potency of NIPP1 as an inhibitor of PPi, but they did not prevent the formation of a ternary NIPP1-EED-PP1 complex. EED had no effect on the function of NIPP1 as a splicing factor or as an endoribonuclease. However, similar to EED, NIPP1 acted as a transcriptional repressor of targeted genes and this NIPP1 effect was mediated by the EED interaction domain. Also, the histone deacetylase 2 was present in a complex with NIPP1. Our data are in accordance with a role for NIPP1 as a DNA-targeting protein for EED and associated chromatin-modifying enzymes. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF
18. A substrate-trapping strategy for protein phosphatase PP1 holoenzymes using hypoactive subunit fusions.
- Author
-
Dan Wu, De Wever, Veerle, Derua, Rita, Winkler, Claudia, Beullens, Monique, Van Eynde, Aleyde, and Bollen, Mathieu
- Subjects
- *
PHOSPHOPROTEIN phosphatases , *DEPHOSPHORYLATION , *BIOACCUMULATION , *ENZYME activation , *GENETIC mutation - Abstract
The protein Ser/Thr phosphatase PP1 catalyzes an important fraction of protein dephosphorylation events and forms highly specific holoenzymes through an association with regulatory interactors of protein phosphatase one (RIPPOs). The functional characterization of individual PP1 holoenzymes is hampered by the lack of straightforward strategies for substrate mapping. Because efficient substrate recruitment often involves binding to both PP1 and its associated RIPPO, here we examined whether PP1-RIPPO fusions can be used to trap substrates for further analysis. Fusions of an hypoactive point mutant of PP1 and either of four tested RIPPOs accumulated in HEK293T cells with their associated substrates and were co-immunoprecipitated for subsequent identification of the substrates by immunoblotting or MS analysis. Hypoactive fusions were also used to study RIPPOs themselves as substrates for associated PP1. In contrast, substrate trapping was barely detected with active PP1-RIPPO fusions or with nonfused PP1 or RIPPO subunits. Our results suggest that hypoactive fusions of PP1 subunits represent an easy-to-use tool for substrate identification of individual holoenzymes. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
19. The Molecular Basis for Substrate Specificity of the Nuclear NIPP1:PP1 Holoenzyme
- Author
-
O'Connell, Nichole, Nichols, Scott R., Heroes, Ewald, Beullens, Monique, Bollen, Mathieu, Peti, Wolfgang, and Page, Rebecca
- Subjects
- *
MOLECULAR structure , *ENZYMES , *PHOSPHOPROTEIN phosphatases , *CHROMATIN , *PROTEIN binding , *PROTEIN-protein interactions - Abstract
Summary: Regulation of protein phosphatase 1 (PP1) is controlled by a diverse array of regulatory proteins. However, how these proteins direct PP1 specificity is not well understood. More than one-third of the nuclear pool of PP1 forms a holoenzyme with the nuclear inhibitor of PP1, NIPP1, to regulate chromatin remodeling, among other essential biological functions. Here, we show that the PP1-binding domain of NIPP1 is an intrinsically disordered protein, which binds PP1 in an unexpected manner. NIPP1 forms an α helix that engages PP1 at a unique interaction site, using polar rather than hydrophobic contacts. Importantly, the structure also reveals a shared PP1 interaction site outside of the RVxF motif, the ΦΦ motif. Finally, we show that NIPP1:PP1 substrate selectivity is determined by altered electrostatics and enhanced substrate localization. Together, our results provide the molecular basis by which NIPP1 directs PP1 substrate specificity in the nucleus. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
20. Synthesis and Characterization of Pseudocantharidins, Novel Phosphatase Modulators That Promote the Inclusion of Exon 7 into the SMN (Survival of Motoneuron) pre-mRNA.
- Author
-
Zhaiyi Zhang, Kelemen, Olga, van Santen, Maria A., Yelton, Sharon M., Wendlandt, Alison E., Sviripa, Vitaliy M., Bollen, Mathieu, Beullens, Monique, Urlaub, Henning, Lührmann, Reinhard, Watt, David S., and Stamm, Stefan
- Subjects
- *
GENE expression , *SPINAL muscular atrophy , *PHOSPHOPROTEIN phosphatases , *MESSENGER RNA , *RIBOSOMES - Abstract
Alternative pre-mRNA splicing is a central element of eukaryotic gene expression. Its deregulation can lead to disease, and methods to change splice site selection are developed as potential therapies. Spinal muscular atrophy is caused by the loss of the SMN1 (survival of motoneuron 1) gene. A therapeutic avenue for spinal muscular atrophy treatment is to promote exon 7 inclusion of the almost identical SMN2 (survival of motoneuron 2) gene. The splicing factor tra2-betal promotes inclusion of this exon and is antagonized by protein phosphatase (PP) 1. To identify new compounds that promote exon 7 inclusion, we synthesized analogs of cantharidin, an inhibitor of PP1, and PP2A. Three classes of compounds emerged from these studies. The first class blocks PP1 and PP2A activity, blocks constitutive splicing in vitro, and promotes exon 7 inclusion in vivo. The second class has no measurable effect on PP1 activity but activates PP2A. This class represents the first compounds described with these properties. These compounds cause a dephosphorylation of Thr-33 of tra2-betal, which promotes exon 7 inclusion. The third class had no detectable effect on phosphatase activity and could promote exon 7 via allosteric effects. Our data show that subtle changes in similar compounds can turn a phosphatase inhibitor into an activator. These chemically related compounds influence alternative splicing by distinct mechanisms. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
21. Expression of a Protein Phosphatase 1 Inhibitor, cdNIPP1, Increases CDK9 Threonine 186 Phosphorylation and Inhibits HIV-1 Transcription.
- Author
-
Ammosova, Tatiana, Yedavalli, Venkat R. K., Xiaomei Niu, Marina Jerebtsova, Van Eynde, Aleyde, Beullens, Monique, Bollen, Mathieu, Kuan-Teb Jeang, and Sergei Nekhai
- Subjects
- *
PHOSPHOPROTEIN phosphatases , *CYCLIN-dependent kinases , *PHOSPHORYLATION , *GENE expression , *CELL lines - Abstract
CDK9/cyclin T1, a key enzyme in HIV-1 transcription, is negatively regulated by 7SK RNA and the HEXIM1 protein. Dephosphorylation of CDK9 on Thr186 by protein phosphatase 1 (PP1) in stress-induced cells or by protein phosphatase M1A in normally growing cells activates CDK9. Our previous studies showed that l-HV-1 Tat protein binds to PP1 through the Tat Q35VC F38 sequence, which is similar to the PP 1-binding RVXF motif and that this interaction facilitates HIV1 transcription. In the present study, we analyzed the effect of expression of the central domain of nuclear inhibitor of PP1 (cdNIPP1) in an engineered cell line and also when cdNIPPi was expressed as part of HIV-1 pNL4-3 in place of nef~ Stable expression of cdNIPP1 increased CDK9 phosphorylation on Thr'86 and the association of CDK9 with 7SK RNA, The stable expression of cdNIPP1 disrupted the interaction of Tat and PP1 and inhibited HIV-1 transcription. Expression of cdNIPP1 as a part of the HIV-1 genome inhibited HIV-1 replication. Our study provides a proof-of-concept for the future development of PP1-targeting compounds as inhibitors of HIV-1 replication. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
22. The extended PP1 toolkit: designed to create specificity
- Author
-
Bollen, Mathieu, Peti, Wolfgang, Ragusa, Michael J., and Beullens, Monique
- Subjects
- *
PHOSPHATASES , *CARRIER proteins , *MOLECULAR models , *TARGETED drug delivery , *CATALYSIS , *BINDING sites - Abstract
Protein Ser/Thr phosphatase-1 (PP1) catalyzes the majority of eukaryotic protein dephosphorylation reactions in a highly regulated and selective manner. Recent studies have identified an unusually diversified PP1 interactome with the properties of a regulatory toolkit. PP1-interacting proteins (PIPs) function as targeting subunits, substrates and/or inhibitors. As targeting subunits, PIPs contribute to substrate selection by bringing PP1 into the vicinity of specific substrates and by modulating substrate specificity via additional substrate docking sites or blocking substrate-binding channels. Many of the nearly 200 established mammalian PIPs are predicted to be intrinsically disordered, a property that facilitates their binding to a large surface area of PP1 via multiple docking motifs. These novel insights offer perspectives for the therapeutic targeting of PP1 by interfering with the binding of PIPs or substrates. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
23. Y65C Missense Mutation in the WW Domain of the Golabi-Ito-Hall Syndrome Protein PQBP1 Affects Its Binding Activity and Deregulates Pre-mRNA Splicing.
- Author
-
Tapia, Victor E., Nicolaescu, Emilia, McDonald, Caleb B., Musi, Valeria, Oka, Tsutomu, Inayoshi, Yujin, Satteson, Adam C., Mazack, Virginia, Humbert, Jasper, Gaffney, Christian J., Beullens, Monique, Schwartz, Charles E., Landgraft, Christiane, Volkmer, Rudolf, Pastore, Annalisa, Farooq, Amjad, Bollen, Mathieu, and Sudol, Marius
- Subjects
- *
SYNDROMES , *PROTEINS , *MESSENGER RNA , *CARRIER proteins , *GENETIC transcription - Abstract
The PQBP1 (polyglutamine tract-binding protein 1) gene encodes a nuclear protein that regulates pre-mRNA splicing and transcription. Mutations in the PQBP1 gene were reported in several X chromosome-linked mental retardation disorders including Golabi-Ito-Hall syndrome. The missense mutation that causes this syndrome is unique among other PQBP1 mutations reported to date because it maps within a functional domain of PQBP1, known as the WW domain. The mutation substitutes tyrosine 65 with cysteine and is located within the conserved core of aromatic amino acids of the domain. We show here that the binding property of the Y65C-mutated WW domain and the full-length mutant protein toward its cognate praline-rich ligands was diminished. Furthermore, in Golabi-Ira-Hall-derived lymphoblasts we showed that the complex between PQBP1-Y65C and WBP11 (WW domain-binding protein 11) splicing factor was compromised. In these cells a substantial decrease in pre-mRNA splicing efficiency was detected. Our study points to the critical role of the WW domain in function of the PQBP1 protein and provides an insight into the molecular mechanism that underlies the X chromosome-linked mental retardation entities classified globally as Renpenning syndrome. [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
24. Characterization of the Condensin Component Cnapl and Protein Kinase Melk as Novel E2F Target Genes Down-regulated by 1,25-Dihydroxyvitamin D₃.
- Author
-
Verlinden, Lieve, Eelen, Guy, Beullens, Ine, Van Camp, Mark, Van Hummelen, Paul, Engelen, Kristof, Van Hellemont, Ruth, Marchal, Kathleen, De Moor, Bart, Foijer, Floris, Riele, Hem Te, Beullens, Monique, Bollen, Mathieu, Mathieu, Chantal, Bouillon, Roger, and Verstuyf, Annemieke
- Subjects
- *
PROTEIN kinases , *PHOSPHOTRANSFERASES , *CELL proliferation , *CELL cycle , *MITOSIS , *MITOSIS regulation , *GENETIC repressors , *BIOCHEMISTRY - Abstract
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) has potent antiproliferative effects characterized by a hampered G1/S transition, cDNA microarrays were used to monitor expression of 21,492 genes in MC3T3-E1 mouse osteoblasts at 1, 6, 12, 24, and 36 h after treatment with 1,25(OH)2D3. Statistical analysis revealed a cluster of genes that were strongly down-regulated by 1,25(OH)2D3 and which not only function in cell cycle regulation and DNA replication but also mediate checkpoint control, DNA repair, chromosome modifications, and mitosis. Because many of these genes were shown earlier to be regulated by the transcriptional repressor E2F4, the intergenic regions of these 1,25(OH)2D3-down-regulated genes were searched for the presence of E2F binding sites. This led to the characterization of two novel E2F target genes, chromosome condensation-related SMC-associated protein 1 (Chap1) and maternal embryonic leucine zipper kinase (Melk). Transfection studies and site-directed mutagenesis confirmed Cnap1 and Melk to be bona fide E2F targets. Repression of Cnap1 and Melk by 1,25(OH)2D3 was confirmed not only in MC3T3-E1 cells but also in several other bone-unrelated cell types. This down-regulation as well as the antiproliferative effect of 1,25(OH)2D3 depended on the pocket proteins p107 and p130 because 1,25(OH)2D3 failed to repress these E2F target genes and lost its antiproliferative action in p107-/-;p130-/- cells but not in pRb-/- cells. [ABSTRACT FROM AUTHOR]
- Published
- 2005
- Full Text
- View/download PDF
25. Structure-Guided Exploration of SDS22 Interactions with Protein Phosphatase PP1 and the Splicing Factor BCLAF1.
- Author
-
Heroes, Ewald, Van der Hoeven, Gerd, Choy, Meng S., Garcia, Javier del Pino, Ferreira, Mónica, Nys, Mieke, Derua, Rita, Beullens, Monique, Ulens, Chris, Peti, Wolfgang, Van Meervelt, Luc, Page, Rebecca, and Bollen, Mathieu
- Subjects
- *
PHOSPHOPROTEIN phosphatases , *KNOTS & splices , *CRYSTAL structure , *DARDARIN , *BIOCHEMICAL models - Abstract
Summary SDS22 is an ancient regulator of protein phosphatase-1 (PP1). Our crystal structure of SDS22 shows that its twelve leucine-rich repeats adopt a banana-shaped fold that is shielded from solvent by capping domains at its extremities. Subsequent modeling and biochemical studies revealed that the concave side of SDS22 likely interacts with PP1 helices α5 and α6, which are distal from the binding sites of many previously described PP1 interactors. Accordingly, we found that SDS22 acts as a "third" subunit of multiple PP1 holoenzymes. The crystal structure of SDS22 also revealed a large basic surface patch that enables binding of a phosphorylated form of splicing factor BCLAF1. Taken together, our data provide insights into the formation of PP1:SDS22 and the recruitment of additional interaction proteins, such as BCLAF1. Graphical Abstract Highlights • The LRRs of SDS22 interact with PP1 helices α5 and α6 • A basic surface patch of SDS22 binds phosphorylated BCLAF1 • Many PP1 holoenzymes contain SDS22 as a third subunit • SDS22 prevents the autodephosphorylation of PP1 The function of protein phosphatase 1 (PP1) is determined by associated regulatory proteins. Heroes et al. describe the structure of the PP1 regulator SDS22, which largely consists of leucine-rich repeats. They also present a biochemically validated model of the PP1:SDS22 complex and use it as a guide for functional studies. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.